UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) ~~May 2~~August 4, 2025

Cryomass Technologies Inc
(Exact name of registrant as specified in its charter)

Nevada	000-56155	82-5051728
(State or other jurisdiction	(Commission File Number)	(IRS Employer
(State or other jurisdiction of	(Commission File Number)	(IRS Employer
of incorporation)		Identification No.)
incorporation)		Identification No.)

1001 Bannock St Suite 612, Denver CO		80204
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code 303-416-7208

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol		Name of each Exchange on which Registered
None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b -2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 18.01. ~~Unregistered~~Other ~~Sale of Equity Securities~~events

OnAs ~~May~~of 2August 4, 2025, ~~Cyomass~~ Cryomass Technologies Inc, a Nevada corporation (the “Company”) ~~entered~~ ~~into~~wishes ato ~~subscription~~inform ~~agreement~~its ~~with~~shareholders athat ~~domestic~~OTC ~~accredited~~Markets ~~investor~~Group ~~(“Subscription~~moved ~~Agreement”),~~the Company’s atrading ~~form~~from ofOTC ~~which~~Pink isto ~~attached hereto~~the ~~and~~Expert ~~incorporated~~Market bydue ~~reference, pursuant~~ to ~~which~~ the Company ~~issued~~not ~~and~~being ~~sold~~current towith anits ~~accredited~~regulatory ~~investor,~~filings. Quotations in ~~the~~Expert ~~initial~~Market ~~tranche of~~securities aare ~~non-brokered~~restricted ~~private~~from ~~placement~~public ~~(the~~viewing. ~~“Private~~Only ~~Placement”),~~broker-dealers ~~17,777,778~~and ~~Units~~professional ~~(“Units”),~~or ~~each~~sophisticated ~~Unit~~investors ~~representing~~are permitted ~~(1)~~to 1view ~~Common~~quotations ~~Stock~~in ~~purchase~~Expert ~~warrant~~Market ~~exercisable~~securities. toDespite ~~purchase~~the ~~one~~restrictions ~~share~~on ofwho ~~the~~can ~~Corporation’s~~view ~~common~~quotations, ~~stock~~the ~~per~~Expert ~~Warrant~~Market ~~(each~~does ~~such~~not ~~share~~impose arestrictions ~~“Warrant~~on ~~Share”)~~who atcan antrade ~~exercise price of US$0~~securities.~~03375~~ ~~per~~For ~~Warrant~~more ~~Share (the “Warrant”)~~information, ~~substantially~~please invisit ~~the form~~Understanding ~~attached to~~ the ~~Subscription~~Expert ~~Agreement~~Market ~~as Appendix C, and (2) 1 Pre~~-~~Funded~~ ~~Common~~OTC ~~Stock~~Markets ~~purchase~~Blog. ~~warrant~~The ~~exercisable to purchase~~Company ~~one~~is ~~Warrant~~working ~~Share~~to atregain ancompliance ~~exercise~~with ~~price~~its ofregulatory ~~US$0.0001~~filings, ~~per~~including ~~Warrant~~10-K ~~Share~~and ~~(the “PFW”)~~10-Q, ~~substantially~~to inreturn ~~the form attached~~ to ~~the Subscription~~a ~~Agreement~~higher asmarket ~~Appendix E for net proceeds of US$400,000~~tier.

~~This~~NOTE ~~Current~~REGARDING ~~Report~~FORWARD onLOOKING Form 8-K is neither an offer to sell nor a solicitation of an offer to buy any securities and shall not constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation, or sale is unlawful. Any securities offered and sold under the Private Placement have not been, and will not be, registered under the Securities Act, or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. In issuing the Units pursuant to the respective agreements, the Company relied on the exemptions from registration under Section 4(a)(2), Rule 506 of Regulation D and Regulation S under the Securities Act.STATEMENTS

~~The~~Any ~~foregoing~~statements ~~descriptions~~in ofthis ~~the~~Current ~~Subscription~~Report on Form ~~Agreement~~8-K door ~~not~~any ~~purport~~exhibit tohereto beabout ~~complete~~future expectations, plans, and ~~are~~prospects ~~qualified~~for inthe ~~their~~Company, ~~entirety~~including bystatements ~~reference~~about toCompany’s future ~~such~~expectations, ~~agreements~~beliefs, ~~and~~goals, ~~documents~~plans, ~~substantially~~or prospects, constitute “forward-looking statements” within the meaning of Section in27A of the ~~forms~~Securities ~~filed~~Act ~~herewith~~and asSection ~~Exhibit~~21E 10of the Exchange Act.1 In some cases you can identify forward-looking statements because they contain words such as “anticipate,” ~~respectively~~“believe,” to“continue,” ~~this~~“could,” ~~Current~~“estimate,” “expect,” ~~Report~~“intend,” on“may,” ~~Form~~“might,” ~~8-K~~“likely,” ~~which~~“plan,” ~~are~~“potential,” “predict,” ~~incorporated~~“project,” ~~herein~~“seek,” by“should,” ~~reference~~“target,” “will,” “would,” or similar expressions and the negatives of those terms.

~~Item~~These 3forward-looking statements involve risks, uncertainties, and assumptions that could cause actual performance or results to differ materially from those expressed or suggested by the forward-looking statements.02 ~~Unregistered~~If ~~Sale~~any of ~~Equity~~these risks or uncertainties materialize, or if any of Company’s assumptions prove incorrect, its actual results could differ materially from the results expressed or implied by these forward-looking statements. These risks and uncertainties include risks associated with: Company’s ability to achieve or maintain profitability, and to effectively manage its anticipated growth; and the risks described in the other filings Company makes with the Securities and Exchange Commission from time to time, including the risks described under the heading “Risk Factors” in Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent quarterly reports on Form 10-Q, and which should be read in conjunction with its financial results and forward-looking statements. All forward-looking statements in this Current Report on Form 8-K or any exhibit hereto are based on information available to Company as of the date hereof, and it does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

~~The information set forth in Item~~ 1.01 of this Current Report on Form 8-K concerning the offer and sale of the shares of Units pursuant to the Subscription Agreement is incorporated herein by reference. The Units under the Subscription Agreement as described in Item 1.01 were offered and sold by the Company in reliance upon an exemption from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506(b) of Regulation D thereunder.

~~Item 9.01. Financial Statements and Exhibits.~~SIGNATURES

Exhibit Number		Description
10.1		Form of Subscription Agreement
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

1Cryomass Technologies Inc

~~NOTE~~/s/ ~~REGARDING~~Christian ~~FORWARD~~Noël ~~LOOKING~~Christian ~~STATEMENTS~~Noël CEO Date: August 4, 2025

Any statements in this Current Report on Form 8-K or any exhibit hereto about future expectations, plans, and prospects for the Company, including statements about Company’s future expectations, beliefs, goals, plans, or prospects, constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. In some cases you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “likely,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will,” “would,” or similar expressions and the negatives of those terms.2

These forward-looking statements involve risks, uncertainties, and assumptions that could cause actual performance or results to differ materially from those expressed or suggested by the forward-looking statements. If any of these risks or uncertainties materialize, or if any of Company’s assumptions prove incorrect, its actual results could differ materially from the results expressed or implied by these forward-looking statements. These risks and uncertainties include risks associated with: Company’s ability to achieve or maintain profitability, and to effectively manage its anticipated growth; and the risks described in the other filings Company makes with the Securities and Exchange Commission from time to time, including the risks described under the heading “Risk Factors” in Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent quarterly reports on Form 10-Q, and which should be read in conjunction with its financial results and forward-looking statements. All forward-looking statements in this Current Report on Form 8-K or any exhibit hereto are based on information available to Company as of the date hereof, and it does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Cryomass Technologies Inc

/s/ Christian Noël Christian Noël CEO Date: May 7, 2025

Filing Compare · Cryomass Technologies, Inc.